Subscription banner for an ophthalmic newsletter

Breaking News

FDA Issues Complete Response Letter to Regeneron for EYLEA HD sBLA on Extended Dosing Intervals
FDA Issues Complete Response Letter to Regeneron for EYLEA HD sBLA on Extended Dosing Intervals Apr 22, 2025 Regeneron Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its supplemental Biologics License Application (sBLA) for EYLEA HD (aflibercept 8 mg).
BVI Medical Receives FDA 510(k) Clearance for Leos Glaucoma Surgical System
BVI Medical Receives FDA 510(k) Clearance for Leos Glaucoma Surgical System Apr 18, 2025 BVI Medical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its innovative glaucoma surgical platform, the Laser Endoscopy Ophthalmic System (Leos).
FDA Accepts Outlook Therapeutics’ Biologics License Application for ONS-5010 in Wet AMD
FDA Accepts Outlook Therapeutics’ Biologics License Application for ONS-5010 in Wet AMD Apr 10, 2025 The U.S. Food and Drug Administration (FDA) has accepted the resubmitted Biologics License Application (BLA) for ONS-5010 (bevacizumab-vikg) from Outlook Therapeutics, for the treatment of wet age-related macular degeneration (AMD).

 

a banner for OBN's Spotlight TV series. Showing 5 people in ophthalmic sector

Industry News

India Approves First 0.05% Atropine Eye Drop for Myopia Control in Children
India Approves First 0.05% Atropine Eye Drop for Myopia Control in Children Apr 24, 2025 Entod Pharmaceuticals has received marketing authorization from the Central Drugs Standard Control Organisation (CDSCO) for India’s first 0.05% atropine eye drop Myatroo XL.
Zhaoke Ophthalmology Enrolls First Patient in Phase 3 Trial of Cyclosporine Ophthalmic Gel for Dry Eye Disease
Zhaoke Ophthalmology Enrolls First Patient in Phase 3 Trial of Cyclosporine Ophthalmic Gel for Dry Eye Disease Apr 21, 2025 Zhaoke Ophthalmology has announced the enrollment of the first patient in its Phase 3 clinical trial evaluating Cyclosporine (CsA) Ophthalmic Gel for the treatment of moderate to severe dry eye disease (DED).
MST Forms Strategic Distribution Partnership with Mani to Expand Ophthalmic Surgical Blade Access in the U.S.
MST Forms Strategic Distribution Partnership with Mani to Expand Ophthalmic Surgical Blade Access in the U.S. Apr 18, 2025 Microsurgical Technology (MST) has announced a strategic partnership with Japanese manufacturer Mani Inc., under which MST will serve as the exclusive distributor of Mani’s ophthalmic surgical blade portfolio in the United States.

Ophthalmic Research News

Researchers Stimulate Retina to Reveal Never-Before-Seen Color Named “Olo”
Researchers Stimulate Retina to Reveal Never-Before-Seen Color Named “Olo” Apr 22, 2025 A multidisciplinary team has developed a novel retinal stimulation technique that enables individuals to perceive a color previously unseen by the human eye.
Postoperative Pilocarpine Use After KDB Goniotomy May Reduce Long-Term Glaucoma Medication Needs
Postoperative Pilocarpine Use After KDB Goniotomy May Reduce Long-Term Glaucoma Medication Needs Apr 22, 2025 Research from the University of Colorado School of Medicine suggests that using pilocarpine eye drops after Kahook Dual Blade (KDB) goniotomy surgery may improve surgical outcomes and reduce the long-term need for glaucoma medications.
Scientists Uncover Structural Insights into RBP3, a Key Protein in Visual Function and Retinal Health
Scientists Uncover Structural Insights into RBP3, a Key Protein in Visual Function and Retinal Health Apr 21, 2025 An international team of scientists has, for the first time, mapped the three-dimensional structure of Retinol-Binding Protein 3 (RBP3).

Ophthalmic Blog

AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health Mar 07, 2025 The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies Dec 23, 2024 The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
2024 Recap: Top 8 FDA Approvals in Ophthalmology Dec 16, 2024 The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe